Otsu, Japan

Yasuzo Hiramatsu


Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1981-1985

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yasuzo Hiramatsu

Introduction

Yasuzo Hiramatsu is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic compositions. With a total of six patents to his name, Hiramatsu's work has had a considerable impact on pain management therapies.

Latest Patents

Hiramatsu's latest patents include a piperazine derivative and an analgesic composition containing the same. This composition features a piperazine derivative represented by a specific general formula, where R1 can be a cyclopropylmethyl group, an isopropyl group, or an allyl group, and R2 represents a phenyl group with a halogen atom or a trifluoromethyl group as a substituent. Another significant patent is for a pharmaceutical composition containing a 1,1,3,5-substituted biuret compound. This compound serves as an active ingredient in an analgesic, anti-inflammatory, or anti-pyretic composition, showcasing Hiramatsu's innovative approach to drug formulation.

Career Highlights

Hiramatsu is currently associated with Taiho Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address various health issues.

Collaborations

Hiramatsu has collaborated with notable colleagues such as Takaji Honna and Hajime Fujimura. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical industry.

Conclusion

Yasuzo Hiramatsu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective pain management therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…